Literature DB >> 23000646

Resolution of macular oedema associated with retinitis pigmentosa after intravitreal use of autologous BM-derived hematopoietic stem cell transplantation.

R C Siqueira, A Messias, J C Voltarelli, K Messias, R S Arcieri, R Jorge.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23000646     DOI： 10.1038/bmt.2012.185

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

Review 2.  Advances in bone marrow stem cell therapy for retinal dysfunction.

Authors:  Susanna S Park; Elad Moisseiev; Gerhard Bauer; Johnathon D Anderson; Maria B Grant; Azhar Zam; Robert J Zawadzki; John S Werner; Jan A Nolta
Journal:  Prog Retin Eye Res       Date:  2016-10-23       Impact factor: 21.198

Review 3.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

Review 4.  Recent advances of stem cell therapy for retinitis pigmentosa.

Authors:  Yuxi He; Yan Zhang; Xin Liu; Emma Ghazaryan; Ying Li; Jianan Xie; Guanfang Su
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

Review 5.  Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials.

Authors:  Sonia Labrador-Velandia; María Luz Alonso-Alonso; Sara Alvarez-Sanchez; Jorge González-Zamora; Irene Carretero-Barrio; José Carlos Pastor; Iván Fernandez-Bueno; Girish Kumar Srivastava
Journal:  World J Stem Cells       Date:  2016-11-26       Impact factor: 5.326

Review 6.  Progress of stem/progenitor cell-based therapy for retinal degeneration.

Authors:  Zhimin Tang; Yi Zhang; Yuyao Wang; Dandan Zhang; Bingqiao Shen; Min Luo; Ping Gu
Journal:  J Transl Med       Date:  2017-05-10       Impact factor: 5.531

7.  Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study.

Authors:  Leila Satarian; Ramin Nourinia; Sare Safi; Mozhgan Rezaei Kanavi; Neda Jarughi; Narsis Daftarian; Leila Arab; Nasser Aghdami; Hamid Ahmadieh; Hossein Baharvand
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

Review 8.  Stem Cell Therapy for Treatment of Ocular Disorders.

Authors:  Padma Priya Sivan; Sakinah Syed; Pooi-Ling Mok; Akon Higuchi; Kadarkarai Murugan; Abdullah A Alarfaj; Murugan A Munusamy; Rukman Awang Hamat; Akihiro Umezawa; Suresh Kumar
Journal:  Stem Cells Int       Date:  2016-05-15       Impact factor: 5.443

9.  Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration.

Authors:  Carina Costa Cotrim; Luiza Toscano; André Messias; Rodrigo Jorge; Rubens Camargo Siqueira
Journal:  Clin Ophthalmol       Date:  2017-05-19

10.  Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging.

Authors:  Carolina Assis P Vilela; Lucas Eduardo B Souza; Rubens C Siqueira; Rodrigo T Calado; Dimas T Covas; Jayter S Paula
Journal:  Stem Cell Res Ther       Date:  2018-06-13       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.